We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
29 hedge funds and large institutions have $79.3M invested in Crescent Biopharma in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 4
2% more capital invested
Capital invested by funds: $77.4M → $79.3M (+$1.92M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 31 → 29 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
14
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.16M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$196K |
| 3 |
SIM
Spark Investment Management
New York
|
-$56.3K |
| 4 |
Morgan Stanley
New York
|
-$33.1K |
| 5 |
Citigroup
New York
|
-$11K |